Sunday, June 21, 2026

HomeHealth NewsFDA approves another over-the-counter naloxone nasal spray

FDA approves another over-the-counter naloxone nasal spray

- Advertisement -

The U.S. Food and Drug Administration has approved another over-the-counter intranasal naloxone product, Rextovy (naloxone hydrochloride), for the emergency treatment of opioid overdose. The nonprescription approval was granted to Amphastar Pharmaceuticals.

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed